MedPath

Investigation of Acute Mood and Cognitive Performance Effects of Beverages Containing Phenolics in Healthy Adults

Not Applicable
Completed
Conditions
Cognitive Function
Interventions
Other: Phenolic Beverage
Registration Number
NCT02675621
Lead Sponsor
PepsiCo Global R&D
Brief Summary

An acute, randomized, placebo controlled, double blinded crossover study in health subjects. Participants will complete 4 intervention arms in random order consisting of a placebo control beverage, a high dose phenolic beverage, a high dose phenolic beverage combined with a fruit extract, and a low does phenolic beverage. The primary objective of the study is to assess the effects of the phenolic compounds, at two different levels, alone and in combination with a fruit extract, on mood and cognitive performance during extended periods of cognitively demanding task performance.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
46
Inclusion Criteria
  • Aged 18 to 49 years
  • Self-report of good health
  • Are not excluded on the basis of the following exclusion criteria
Exclusion Criteria
  • Are a smoker
  • Have food allergies or sensitivities to any of the ingredients contained in the investigational product or any other foodstuff
  • Currently take medication except the contraceptive pill
  • Have habitually used dietary supplements within the last month (defined as more than 3 consecutive days or 4 days in total)
  • Have sleep disturbances and/or are taking sleep aid medication Are employed in a job that includes night shift work
  • Have a Body Mass Index (BMI) outside of the range 18-35 kg/m2or weigh less than 50kg or more than 85kg.
  • Have high blood pressure (systolic over 139 mm Hg or diastolic over 89 mm Hg)
  • Have a history of neurological, vascular or psychiatric illness including epilepsy or seizures (excluding depressive illness and anxiety)
  • Have a history of anxiety or a current diagnosis of anxiety or depression
  • Are pregnant, trying to get pregnant or breast feeding
  • Have a recent history of (within 12 months of screening visit) or strong potential for alcohol or substance abuse. Alcohol abuse is defined as more than 60g (men) / 40g (women) pure alcohol per day (7 / 5.5 units)
  • Have learning difficulties or dyslexia
  • Have visual impairment that cannot be corrected with glasses or contact lenses
  • Have frequent migraines that require medication (more than or equal to 1 per month)
  • Have disorders of the blood (e.g. anaemia, hemophilia, thrombocytosis)
  • Have a heart disorder or a history of vascular illness
  • Have a respiratory disorder that requires regular medication (Note: participants with asthma who only take their medication occasionally/as required are eligible for this study)
  • Have a diagnosis of type I or type II diabetes
  • Have a history of renal or hepatic disease, or other severe diseases of the gastrointestinal tract (e.g. iron accumulation, iron utilization disorders, hypercalcaemia, hypercalciuria), that are likely to interfere with metabolism/absorption/secretion of the product under investigation
  • Have any health condition that would prevent fulfillment of the study requirements
  • Are currently or have in the past 8weeks participated in other clinical or nutrition intervention studies
  • Have participated in the BPNRC's recent stress study
  • Do not have a bank account (required for payment)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
ControlPhenolic BeverageMix 1 flavored still beverage
Phenolic beverage 2Phenolic BeverageMix 3 flavored still beverage with a high dose phenolic extract1 and a fruit extract
Phenolic beverage 1Phenolic BeverageMix 2 flavored still beverage with a high dose phenolic extract
Phenolic beverage 3Phenolic BeverageMix 4 flavored still beverage with a low dose phenolic extract3 and a fruit extract
Primary Outcome Measures
NameTimeMethod
Change in mental fatiguePre, 1, 3, and 6 hours post-beverage consumption
Secondary Outcome Measures
NameTimeMethod
Changes in mood and cognitive functionPre, 1, 3, and 6 hours post-beverage consumption

During each assessment mood and psychological state will be assessed before and after performance of an observed multi-tasking stressor via completion of the 'State' subscale of the State-Trait Anxiety Inventory and computerised versions of the Bond-Lader visual analogue mood scales and separate visual analogue scales (VAS) measuring subjective stress, relaxation and calmness.

Trial Locations

Locations (1)

Northumbria University

🇬🇧

Newcastle upon Tyne, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath